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Abstract
Background: A comprehensive evidence base is needed to support recommenda-
tions for the dietetic management of adults with chronic kidney disease (CKD). The 
present study aimed to determine the effect of dietary interventions with dietitian 
involvement on nutritional status, well- being, kidney risk factors and clinical out-
comes in adults with CKD.
Methods: Cochrane Central Register of Controlled Trials, CINAHL, MEDLINE, 
PsycINFO and EMBASE.com were searched from January 2000 to November 2019.
Intentional weight loss and single nutrient studies were excluded. Risk of bias was 
assessed using the Cochrane risk- of- bias tool. Effectiveness was summarised using 
the mean difference between groups for each outcome per study.
Results: Twelve controlled trials (1906 participants) were included. High fruit and 
vegetable intake, as well as a multidisciplinary hospital and community care pro-
gramme, slowed the decline in glomerular filtration rate in adults with stage 3– 4 
CKD. Interventions addressing nutrition- related barriers increased protein and en-
ergy intake in haemodialysis patients. A Mediterranean diet and a diet with high n- 3 
polyunsaturated fatty acids improved the lipid profile in kidney transplant recipients.
Conclusions: A limited number of studies suggest benefits as a result of dietary inter-
ventions that are delivered by dietitians and focus on diet quality. We did not identify 
any studies that focussed on our primary outcome of nutritional status or studies that 
examined the timing or frequency of the nutritional assessment. This review empha-
sises the need for a wider body of high- quality evidence to support recommendations 
on what and how dietetic interventions are delivered by dietitians for adults with CKD.
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I N TRODUC TION
Dietary interventions appropriate to the stage of chronic kid-
ney disease (CKD) and treatment modality (including dialysis 
and kidney transplantation) are critical to the management 
and progression of the condition. Recommendations have 
traditionally focused on nutrients considered to impact 
upon kidney disease progression, as well as those that ac-
cumulate as a result of a declining glomerular filtration 
rate. Prescriptive diets have focused on restricting intake of 
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sodium, protein, potassium, phosphorus and fluid, yet tar-
geted single and multiple nutrient restrictions in CKD have 
demonstrated largely inconclusive effects on CKD progres-
sion and cardiovascular events.1,2 Those with CKD report 
that living with these dietary restrictions is overwhelming, 
challenging and burdensome,3,4 which is reflected in poor 
adherence.5 To support and implement best evidence- based 
practice, dietitians are seeking to identify, appraise and 
summarise contemporary evidence pertaining to the effi-
cacy and implementation of dietary interventions delivered 
to people with CKD. In 2017, a Cochrane review of dietary 
interventions in CKD,6 encompassing whole diet, dietary 
patterns or behaviour modification dietary interventions 
focusing on clinical outcomes such as mortality and cardio-
vascular events, concluded that dietary intervention studies 
were of very low quality and insufficient to guide clinical 
practice. This review, however, did not hone in on inter-
ventions with dietitian involvement (either in the planning 
or delivery stage), nor examine intervention timing or fre-
quency. Therefore, in 2018, the British Dietetic Association 
Renal Nutrition Group formed a committee to investigate 
the evidence for the efficacy and timing and/or frequency 
of dietary interventions, involving dietitians, for adults with 
CKD. A full search and appraisal of existing guidelines1,2,7– 10 
using the AGREE II framework was undertaken. Generally, 
limited evidence was found in the existing guidelines for rec-
ommendations regarding the initiation, timing, frequency 
and delivery of the dietetic care process in the management 
of CKD, and dietitian involvement was unclear (personal 
communication with the British Dietetic Association Renal 
Nutrition Group Executive, 2019). Because dietitians hold 
clinical expertise in the nutritional management of long- 
term conditions, focusing on studies with their involvement 
could highlight meaningful evidence.
In light of the lack of evidence in existing guidelines and 
the 2017 Cochrane review,6 this review adopts a broader and 
pragmatic remit and includes evidence from randomised, 
quasi- randomised and non- randomised controlled trials. The 
objective was to review the evidence base for dietary interven-
tions with dietetic involvement in the design or delivery, aim-
ing to examine the impact of nutrition assessment and dietary 
interventions on nutritional outcomes, quality of life (QoL), pa-
tient reported experience measures (PREMs), kidney and car-
diovascular disease (CVD) risk factors and clinical outcomes 
in adults with CKD. To enhance the clinical applicability of 
this review, studies must have reported implementation details 
including the timing or frequency of the dietary intervention.
M ETHODS
Protocol registration
The protocol for the systematic review was registered with 
PROSPERO (CRD42019151455).11 The present study is re-
ported in accordance with the Preferred Reporting Items for 
Systematic Reviews and Meta- Analyses checklist.12
Literature search
We searched Cochrane Central Register of Controlled 
Trials (CENTRAL, via the Cochrane Library), CINAHL, 
MEDLINE and PsycINFO (all via Ebscohost), and EMBASE.
com, from January 2000 to November 2019, for randomised 
controlled trials (RCTs), quasi- RCTs and non- randomised 
trials that were designed and/or delivered by dietitians in 
adults with any stage of CKD with a follow- up of at least 
6  months. The search year 2000 was chosen to reflect the 
year that the first K/DOQI nutritional guidelines for kidney 
disease were published.7 Studies of multi- nutrient, dietary 
pattern or ‘whole diet’ behavioural, lifestyle or nutrition 
counselling interventions for the purpose of improving 
nutritional outcomes, QoL, risk factors for kidney, or car-
diovascular disease and clinical outcomes were eligible for 
inclusion. A detailed search strategy for EMBASE is pro-
vided in the Supporting information, Doc. S1. We checked 
bibliographies of original studies and recent review articles 
for additional relevant studies.
Study selection
Two of the investigators (TJB and HM/HW) indepen-
dently screened titles and abstracts for all identified 
studies and retrieved the full texts of potentially relevant 
studies for further screening. Full- text assessments were 
performed according to the a priori selection criteria that 
are detailed in the registered protocol.11 Studies were in-
cluded if they were: (i) full- text articles published from 
year 2000 onwards or accepted for publication, and writ-
ten in the English language; (ii) RCTs, quasi- RCTs and 
non- RCTs evaluating the effect of multi- nutrient or ‘whole 
diet’ behavioural, lifestyle or nutrition counselling inter-
ventions, including nutritional assessment, with dietitian 
involvement in the development or delivery of the inter-
vention; (iii) conducted in adults with CKD stage 1 to 5, 
including individuals with kidney failure treated with 
haemodialysis, peritoneal dialysis, kidney transplantation 
or supportive/conservative care; and (iv) had a follow- up 
of ≥ 6 months and reported details of the frequency and 
timing of the intervention. Any setting and any mode of 
delivery were included. Types of control group included 
any other type of intervention, no treatment and standard 
care. Studies focusing on weight loss or single nutrients 
were excluded because these have been reviewed elsewhere 
or are being updated.13– 16
Data extraction
Two of the investigators (TJB and HM/HW) independently 
extracted data on: (i) study characteristics (first author, year 
of publication, trial registration, country, sponsor/funding, 
study design, duration of intervention and follow- up, sample 
size and eligibility criteria); (ii) participants’ characteristics 
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(age, gender, and baseline estimated glomerular filtration 
rate [eGFR]); (iii) methods for dietary implementation and 
tailoring/modification reported using the Template for 
Intervention Description and Replication (TIDieR) check-
list17; and (iv) outcome measures. Our primary outcome was 
nutritional status, and other outcomes included QoL, nu-
tritional outcomes such as diet quality and anthropometry, 
PREMs, kidney and CVD risk factors (hyperlipidaemia, 
hyperglycaemia, hypertension and proteinuria) and clinical 
outcomes.
Assessment of risk of bias
Two of the investigators (TJB and HW) independently as-
sessed the risk of bias at the study level using Cochrane's 
risk- of- bias assessment,18 with disagreements discussed with 
a third investigator (HM) to reach a consensus. Reviewers 
were not blinded with respect to study authors, institution or 
journal. We assessed trials as ‘high’ risk for attrition bias if 
attrition was ≥ 30%. We searched for both trial registrations 
and protocols to assess selective outcome reporting. For 
cluster- randomised trials, we made an additional assessment 
regarding the timing of randomisation and recruitment to 
clusters.19
Data synthesis
The outcomes were reported by CKD stage and treatment mo-
dality, sub- grouped by type of intervention. Effectiveness was 
summarised using the mean difference between groups in each 
study, at the last available follow- up, for each outcome. In studies 
where the mean difference between groups at follow- up was not 
reported, the mean change from baseline or the absolute values 
at baseline and follow- up for each group were reported and the 
F I G U R E  1  PRISMA flow diagram. Flow chart describes the process of selection of studies within the systematic review
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summary of effectiveness was assessed as unclear. Given the 
limited number of studies and variation in the types of interven-
tions, comparisons and study populations, it was not appropri-
ate to pool any of the data in meta- analysis or conduct further 
statistical analyses, including statistical evaluation of publica-
tion bias, sensitivity analysis or measurement of heterogeneity.
R E SU LTS
Study selection
Figure 1 details the flowchart of the study selection process. 
Our electronic search identified 5459 potentially relevant re-
cords. One additional record was identified through other 
sources. Of these, 1244 were excluded as duplicates and 4186 
were excluded after screening for titles and abstracts. We per-
formed full- text screening of the remaining 30 records, and 
12 studies (from 16 articles  –   four companion papers) were 
included. The characteristics of the included studies, includ-
ing details of the providers of the interventions and compara-
tors, are provided in the Supporting information (Table S1). 
There were 10 RCTs, one quasi- RCT and one non- randomised 
trial with participants self- allocating to groups. Participants 
included people with CKD stages 3 and/or 4 (n = 5 studies), 
haemodialysis (n  =  3 studies) and kidney transplantation 
(n = 4 studies). The mean age of participants ranged from 41 
to 69 years; mean percentage males within each study ranged 
from 26.9% to 72%. The mean eGFR ranged from 21.6 to 
42.6 mL min−1 1.73 m−2 for people with stages 3– 4 CKD and 
48.4 to 53.8 mL min−1 1.73 m−2 for kidney transplant recipients.
The types of dietary interventions varied, although there 
were three broad models of delivery: personalised interven-
tions; multidisciplinary team (MDT) interventions; and 
food- based interventions. Personalised interventions in-
cluded: telehealth to support dietary self- management20,21; 
individualised nutrition and exercise counselling22; lifestyle 
advice using self- monitoring23; individualised nutrition edu-
cation24; and dietary intervention tailored to patient- specific 
barriers.25,26 MDT interventions included: cooking classes 
plus an exercise programme27 and an integrated (hospital and 
community) care programme.28 Food- based interventions 
included: diet to increase base- reducing fruit and vegetable 
intake to reduce dietary acid by 50%29– 31; diet to increase the 
intake of omega- 3 polyunsaturated fatty acids (PUFAs)32; and 
Mediterranean diet.33– 35 More information on each interven-
tion, including delivery format, setting and tailoring, is pro-
vided in the TIDieR checklist in the Supporting information 
(Table S2). The study sample sizes ranged from 37 to 570 and 
the total sample was 1906 participants. The mean length of 
active intervention ranged from 6 months to 5 years.
Assessment of risk of bias
Risk of bias was ‘unclear’ in most of the domains (Figure 2; 
see also the Supporting information, Doc S1). Nine of the 12 
studies were rated as ‘high’ risk of performance bias because 
the participants and/or the providers were not blinded to the 
intervention. We rated nine studies as ‘low’ risk of attrition 
bias. Three studies were rated as ‘high’ risk of bias in three 
domains each, including two studies that did not randomly 
allocate participants. All four cluster RCTs were rated high 
risk of bias relating to the timing of recruitment of the clus-
ters.  Other issues to highlight are: (i) very few studies re-
ported whether confounding factors such as lipid- lowering 
drugs, antihypertensive and steroid medications were 
equally balanced across groups at baseline or controlled for 
in analyses and (ii) none of the studies that reported on clini-
cal outcomes were adequately powered to detect changes in 
such endpoints.21,23,28
Effects of dietary intervention
Table 1 summarises effectiveness and includes outcome 
data from 11 of the 12 included studies. We only extracted 
F I G U R E  2  Risk of bias summary. Summary describes review 
authors’ judgements about each risk of bias item for each included study. 
?, risk of bias is unclear; +, low risk of bias; – , high risk of bias
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feasibility data20 and not effectiveness data21 for one study 
because the control group received a delayed intervention, 
and so did not receive 6 months of the same treatment (our 
inclusion criteria states a minimum follow- up of 6- months). 
Detailed outcome results are provided in the Supporting in-
formation (Table S3).
CKD stages 3 and 4
Personalised interventions
Participants of a dietitian- led, theory- based, telehealth 
coaching intervention20 to support dietary self- management 
viewed it as an acceptable alternative to face- to- face clinic 
consultations. The study uptake rate was 35%, with 93% of 
the intervention group and 98% of the control group com-
pleting the study. Intervention participants received phone 
calls every 2 weeks for 3 months and tailored text messages 
for 6  months to encourage a diet following guidelines for 
CKD. The control group had usual care (UC) for the initial 
3  months followed by non- tailored educational text mes-
sages for months 3– 6. Eighty- two percent of participants 
needed at least two calls to begin putting planned dietary 
intentions in place. All of the participants in the intervention 
identified the tailored text messages as useful for supporting 
dietary self- management, and 27 (69%) of the control group 
reported that the non- tailored text messages were useful for 
supporting change.
Multidisciplinary team interventions
Group- based cooking and exercise classes in addition to 
standard care did not significantly improve against a priori 
defined targets for kidney and CVD risk factors (lipids, blood 
pressure [BP],28 eGFR, proteinuria) in 40 participants at 
12 months.27 Process evaluation indicated an improvement 
in exercise frequency and concern over health condition in 
the intervention group and improved communication with 
healthcare providers in the control group. An integrated 
community- based care programme (in addition to standard 
care plus a group- based educational programme) showed 
inconsistent results across outcomes in 387 participants at 
24 months.28 There were no significant differences between 
groups for body mass index, low- density lipoprotein (LDL), 
proteinuria, QoL, all- cause mortality, cardiovascular events 
(acute myocardial infarction and stroke), end- stage kidney 
disease or 50% increase in serum creatinine from baseline. 
There were significant differences between groups indicat-
ing improvement for intervention participants for eGFR 
(adjusted mean difference 2.74; 95% confidence interval 
[CI]  =  0.60– 4.50  mL  min−1  1.73  m−2), triglycerides (mean 
difference −18.15; 95% CI = −35.5 to −0.8 mg dL−1) and the 
composite clinical endpoint of acute myocardial infarc-
tion, stroke, end- stage kidney disease and a 50% increase 
in serum creatinine from baseline (hazard ratio = 0.59; 95% 
CI = 0.37– 0.96). Systolic BP (SBP) was lower in the control 
group compared to intervention participants during follow-
 up (mean difference 5.37; 95% CI = 3.4– 7.3).
Food- based interventions
Increasing the intake of fruit and vegetables compared to 
sodium bicarbonate showed additional improvement in 
some kidney and CVD risk factors (albuminuria, SBP) and 
weight (mean difference −6.4 kg at 12 months; p < 0.01) and 
no change in plasma potassium at 12 months (mean plasma 
potassium 4.1 ± 0.2 mEq L−1 for both groups at baseline and 
12 months) (one study, 73 participants with stage 4 CKD).30 
The same type of intervention by the same study team 
showed improvement in some kidney and CVD risk factors 
(albuminuria, eGFR, LDL, SBP), diet quality, and body com-
position at 5  years (one study, 108 participants with stage 
3 CKD)29,31 when fruit and vegetable intake was increased 
compared to UC. The 5- year net eGFR decrease was signifi-
cantly less with sodium bicarbonate (−12.3; 95% CI = −12.9 
to −11.7 mL min−1 1.73 m−2) and fruit and vegetables (−10.0; 
95% CI = −10.6 to −9.4 mL min−1 1.73 m−2) compared to UC 
(−18.8; 95% CI = −19.5 to −18.2 mL min−1 1.73 m−2) but was 
not significantly different between sodium bicarbonate and 
fruit and vegetable groups. The fruit and vegetable group 
showed additional improvement for body mass index, diet 
quality, LDL and SBP at 5 years compared to sodium bicar-
bonate (all p < 0.05). The 5- year net change in fruit and veg-
etable intake in cups per day was 2.1 (2.0– 2.2) for fruit and 
vegetables, 0.0 (−0.07 to 0.1) for sodium bicarbonate and was 
0.0 (−1.0 to 0.09) for UC. LDL (mg dL−1) decreased by 45.5 
(−51.0 to −40.0) with fruit and vegetables, by 21.5 (−27.0 to 
−16.0) with sodium bicarbonate and by 14.3 (−20.6 to −9.2) 
with UC. SBP decreased with fruit and vegetables by an addi-
tional 8 mmHg compared to sodium bicarbonate (p < 0.05) 
and an additional 13.3 mmHg compared to UC (p < 0.05). 
There was no difference between the three groups for high- 
density lipoprotein at 5 years.29,31
Kidney transplantation
Personalised interventions
Individualised lifestyle interventions (including diet and 
exercise) that used motivational interviewing22 or behav-
iour change techniques23 did not improve lipids, QoL or 
functional markers (two studies, 139 participants) after 
6– 12 months compared to UC or control. However, in one of 
these studies, UC involved relatively well- resourced dietetic 
input of between one and four consultations within 1 year.22 
One of these studies23 also reported on BP, eGFR and al-
buminuria and showed no significant difference between 
groups; there were no serious cardiac events reported in ei-
ther group. That study23 reported improvements in weight 
(mean difference −2.47 kg; 95% CI = −4.01 to −0.92) and fat 
mass (mean difference −1.53  kg; 95% CI  =  −2.94 to −0.12) 
but not in skinfold thickness and fat free mass at 6 months 
(interim report – follow- up planned for 10  years) com-
pared to control. The other study22 measured nutritional 
status (patient- generated subjective global assessment) and 
reported that two of 19 intervention participants had ‘sus-
pected malnutrition’ at baseline and another intervention 
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participant developed ‘suspected malnutrition’ at 6 months 
following hospitalisations.
Food- based interventions
A diet to increase the intake of omega- 3 PUFAs and to 
decrease the omega- 6:omega- 3 ratio showed improve-
ment in some kidney and CVD risk factors (lipid profile, 
proteinuria, albuminuria), some components of diet qual-
ity (saturated fat, polyunsaturated fat, n- 3 PUFA, n- 6:n- 3 
PUFA ratio) and body weight compared to standard di-
etetic advice in 50 participants at 6 months. There was no 
difference in eGFR, total fat intake, monounsaturated fat 
or n- 6 PUFA.29 A Mediterranean diet intervention showed 
improvement in some kidney and CVD risk factors (total 
cholesterol, triglycerides) compared to a low- fat diet in 37 
participants at 6 months. There was no difference in HDL, 
BP or body composition (lean mass increased in controls) 




One study24 compared three groups: individualised nutrition 
education by a dietitian with dedicated time (2 h month−1 pa-
tient−1 delivered as 2 × 15- min sessions per week), nutrition 
education by a hospital dietitian (around other duties) and 
standard care (dietitian not specifically trained for CKD 
management) on management of osteodystrophy (570 par-
ticipants, data reported for 394 [69%] completers only). Both 
intervention group dietitians were trained in stage- based be-
haviour change and dietary management of CKD. Dietary 
knowledge and stages of change were assessed, although 
only within groups (not between groups); study contamina-
tion was also reported. Individualised nutrition education 
by a dietitian with dedicated time was associated with an 
improvement in dietary knowledge score from baseline, al-
though improvement in behaviour stage from ‘preparation’ 
to ‘action’ at 6  months was not maintained at 12  months 
follow- up.
Two studies25,26 by the same study team tailored a dietary 
intervention to patient- specific barriers (poor nutritional 
knowledge, poor appetite, help needed with shopping or 
cooking, low fluid intake, inadequate dialysis dose, depres-
sion, difficulty chewing, difficulty swallowing, gastroin-
testinal symptoms and acidosis). The pilot study26 did not 
report on any of our pre- specified outcomes. The follow- on 
study25 demonstrated that an intervention tailored to ad-
dress patient- specific barriers increased protein and energy 
intake (mean difference 4.7 kcal kg−1 day−1 for energy and 
0.2 g kg−1 day−1 for protein intake (p < 0.05) at 12 months), al-
though nutritional status, body composition or QoL did not 
change at 12 months compared to UC provided by nephrol-
ogists, dietitians and social workers (one study, 208 partic-
ipants). At baseline, intervention participants were more 
likely to have low fluid intake and difficulty swallowing, 
whereas control participants were more likely to have poor 
appetite. The most common barriers in both groups were 
poor nutritional knowledge and poor appetite. There were 
significant improvements at 12 months in favour of the in-
tervention in terms of the percentage of participants over-
coming barriers related to poor nutritional knowledge, help 
needed with shopping or cooking and difficulty swallowing, 
compared to UC.
DISCUSSION
As far as we are aware, this is the first review of nutrition 
interventions, for adults with CKD, that are specifically 
delivered or designed by dietitians, focusing on studies of 
multi- nutrient, dietary pattern or ‘whole diet’ behavioural, 
lifestyle or nutrition counselling interventions, within con-
trolled study designs. Our review complements the 2017 
Cochrane review6 on nutrition interventions in CKD, which 
assessed mortality and cardiovascular events. By contrast to 
the Cochrane review, our review examined a broader range 
of outcomes and focussed on dietary interventions provided 
or developed by dietitians specifically. Our review also com-
plements the Kidney Disease Outcomes Quality Initiative 
(KDOQI) National Kidney Foundation 2020 guidelines for 
nutrition in CKD, where the authors recognise that they 
provide information on dietary management rather than all 
intervention strategies.36
The evidence is largely uncertain, with few available 
studies, a range of interventions and outcomes measured, 
and mixed results of limited strength. A limited number 
of studies suggest some benefits of nutrition interventions 
that are delivered by dietitians and focus on dietary qual-
ity. High fruit and vegetable intake and a multidisciplinary 
group- based programme may slow eGFR decline in stages 
3– 4 CKD. Furthermore, an increased intake of fruit and veg-
etables appeared to confer additional advantage in improv-
ing BP control, LDL cholesterol levels and weight reduction 
compared to the use of sodium bicarbonate and standard 
care. A Mediterranean diet and a diet with a high n- 3 PUFA 
intake may improve blood lipids in adults who have had a 
kidney transplant. These study findings support the impor-
tance of diet quality and a holistic approach to diet and indi-
cate a role for further research into this subject.
In haemodialysis, individualised interventions address-
ing nutrition- related barriers may increase protein and 
energy intake. Increases in energy and protein intake of 
200– 350 kcal and 6– 11 g protein day−1 from foods and food 
fortification may provide economic benefits if reducing the 
requirement for prescribed oral nutritional supplements. 
This supports the development and validation of tools for 
use in outpatient/ambulatory settings to identify not only 
nutritional risk, but also specific barriers that may impact on 
nutritional risk or nutritional status. Overcoming barriers 
requires the identification of these barriers and a multidis-
ciplinary approach to the treatment of nutritional concerns. 
Many studies on the use of oral nutrition supplements in 
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haemodialysis were excluded from this review as a result of 
their duration being less than 6 months. Therefore, we were 
unable to evaluate the effect of supplements on nutritional 
status or other outcomes.
As a result of the limited number of studies, of which 
there was considerable variation in the type of interventions 
and comparators, meta- analysis was not possible. There is 
insufficient and poorly reported data on nutritional status, 
and there were no studies identified that met the inclusion 
criteria and examined the timing or frequency of assess-
ment of nutritional status. Furthermore, none of the studies 
was primarily aimed at maintaining or improving nutri-
tional status, which was the primary outcome of this review. 
Frequency of nutritional assessment to improve or maintain 
a well- nourished state is a key question for the dietetic work-
force, and an innovative trial design may be needed to deter-
mine whether more or less frequent nutrition assessment has 
an impact on clinical outcomes such as malnutrition, hospi-
talisation, quality of life and mortality.
Innovative study design and methods of delivery may be 
required to deliver dietetic interventions including ongo-
ing support for dietary change, at scale. One study by Kelly 
et al.20 suggests that newer methods of delivery such as text 
messaging may be well received by service users and pro-
vides a way of optimising the use of limited dietetic resource. 
This was the only included study to report on the patient ex-
perience of the intervention. Our search identified a protocol 
for a study (KIDNEYTEXT),37 which has subsequently pub-
lished feasibility results in January 2021.38 KIDNEYTEXT 
included three text messages per week (in addition to stan-
dard care) designed to improve dietary behaviours, and 
demonstrated that this type of intervention was feasible and 
acceptable to people on maintenance haemodialysis. Further 
research is required to determine whether generic and/or 
individualised text messaging may be effective, and provide 
a practical solution to improve access to dietetics services 
within staffing and economic constraints.
Strengths and limitations of the review
The remit was to review the evidence for the effectiveness of 
dietary interventions in adults with CKD within the context 
of studies that reported implementation details including 
the timing or frequency of the dietary intervention aim-
ing to increase clinical applicability. Studies of weight loss 
and single nutrient studies were excluded because they have 
already been reviewed or are being updated.13– 16 We have 
evaluated the evidence from studies that investigate differ-
ent types of dietary modification, such as increasing PUFAs; 
lifestyle interventions that are underpinned by behaviour 
change theory, including self- monitoring and motivational 
interviewing; interventions using different method of deliv-
ery, such as text messaging and telephone; and interventions 
that investigate different practices, including integrated care 
(hospital and community) and dietitian care with dedicated 
time. As well as extracting information on how each study 
was implemented, using the TIDieR principles, we have ex-
tracted process indicators such as participation, retention, 
fidelity and satisfaction. There is insufficient evidence to 
make recommendations on what and how dietetic inter-
ventions are delivered. The lack of available evidence may 
reflect inherent difficulties in conducting controlled trials 
in dietetics. We have already highlighted the variation in 
comparators and the complexity of evaluating multicompo-
nent interventions. Other inherent difficulties include the 
necessary assumption that patient populations are relatively 
homogenous, although the main principle of a dietetic inter-
vention is its individualised nature based on a complex as-
sessment including physical, anthropometric, psychological 
and socio- economic factors. An innovative pragmatic trial 
design is needed to capture the assessment and identified 
need process, aiming to measure effectiveness.
Despite a comprehensive and wide search of the litera-
ture, widening the search to include non- randomised trials 
as well as RCTs, the evidence identified was limited. There 
were no identified studies of dietary interventions in adults 
undergoing peritoneal dialysis, in supportive care or with 
CKD stages 1 and 2, and so it was not possible to assess the 
effectiveness of such interventions in the early stages of 
CKD or with these specific treatment modalities. We can 
be confident that we have identified all the controlled in-
tervention evidence available reporting on the timing and/
or frequency of dietetic interventions, excluding single nu-
trient and weight loss interventions, for adults with CKD, 
which was designed or provided by dietitians, with a du-
ration of at least 6 months follow- up. It is possible that we 
missed some published studies with dietitian involvement 
because it was not reported in the abstract; however, in an 
attempt to mitigate this, we obtained the full- text article for 
further assessment, if it appeared in the abstract that the 
intervention was multidisciplinary and it met our other in-
clusion criteria.
Risk of bias was generally ‘unclear’, with a high risk of 
performance bias as a result of a lack of blinding of partic-
ipants in nine studies. There were other important issues 
with the quality of the evidence that impact on the cer-
tainty of the evidence: very few studies reported whether 
confounding factors such as lipid- lowering and antihyper-
tensive medications were equally balanced across groups at 
baseline or controlled for in subsequent analyses; none of 
the studies were adequately powered to detect changes in 
clinical endpoints.
Broadly, there was inconsistency both within and across 
studies in terms of whether an intervention showed im-
provement or no difference compared to the control; where 
there was no difference between groups, both groups had 
improved from baseline. In general, most studies were small, 
and may have been underpowered to detect differences in 
outcomes, particularly as a result of heterogeneity in the 
studied populations, an inadequate length of follow- up for 
clinical events and myriad factors influencing changes to 
behaviour beyond the control of researchers in these studies. 
Standard care control groups varied considerably across the 
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studies. Standard care usually involved some dietetic input, 
ranging from UC from a hospital dietitian to individualised 
dietary counselling and regular review by a renal (kidney) 
dietitian. In four studies,20,27,30,31 the provider of the control 
was not reported; in two studies,23,28 there was no dietetic 
input in the control group, and six studies22,24– 26,32,34 clearly 
state that a dietitian provided care in the control group. In 
one of these studies, control participants received up to 
four consultations with a renal (kidney) dietitian during 
12 months following kidney transplant.22 Therefore, many 
of these studies assessed enhanced dietetic input rather 
than dietetic input per se. This might at least partially ex-
plain the lack of effect for interventions and standard care 
may reflect an adequate level of care with some interven-
tions. In addition, many of the included studies were mul-
ticomponent interventions (e.g., interventions including 
diet and physical activity) and so it is difficult to identify 
any potential effects of the dietary component alone, within 
these studies.
CONCLUSIONS
The evidence is largely uncertain. A limited number of stud-
ies suggest some benefits of dietary interventions that are 
delivered by dietitians and focus on diet quality or whole 
diet interventions. There is currently insufficient evidence 
to draw any conclusions for dietetic practice, specifically re-
garding the initiation, timing and frequency of the delivery 
of dietary interventions, as well as the implementation of 
such by dietitians. This review highlights the need for more 
high- quality evidence to support recommendations on what 
and how dietetic interventions are delivered and measured 
by dietitians for adults with CKD.
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